RNA Editing Revolutionizes Genetic Disorder Treatments
Wave Life Sciences, a Massachusetts biotechnology firm, made headlines. They became the first company to treat a genetic condition using RNA editing in clinical trials. This milestone marks the growing significance of RNA in medicine, especially following the success of mRNA vaccines during the COVID-19 pandemic. About RNA Editing RNA editing is a process that corrects mistakes in messenger RNA (mRNA) after its synthesis from DNA. Cells use mRNA to produce proteins. Errors in mRNA can lead to faulty proteins, causing various disorders. RNA editing fixes these errors before the mRNA is translated into proteins. How RNA Editing Works One key method involves adenosine deaminase acting on RNA (ADAR) enzymes. These enzymes convert adenosine, a building block of RNA, into inosine. Inosine behaves like guanosine, another RNA building block. This conversion tricks the cell into correcting the mRNA, allowing it to produce functional proteins. Guide RNA and Targeting Scientis...